PERITONEOVENOUS ASCITES SHUNTS
\pˌɛɹɪtˈə͡ʊnə͡ʊvnəs ɐssˈa͡ɪts ʃˈʌnts], \pˌɛɹɪtˈəʊnəʊvnəs ɐssˈaɪts ʃˈʌnts], \p_ˌɛ_ɹ_ɪ_t_ˈəʊ_n_əʊ_v_n_ə_s ɐ_s_s_ˈaɪ_t_s ʃ_ˈʌ_n_t_s]\
Sort: Oldest first
-
An operation for the continuous emptying of ascitic fluid into the venous system. Fluid removal is based on intraperitoneal and intrathoracic superior vena cava pressure differentials and is performed via a pressure-sensitive one-way valve connected to a tube traversing the subcutaneous tissue of the chest wall to the neck where it enters the internal jugular vein and terminates in the superior vena cava. It is used in the treatment of intractable ascites.
By DataStellar Co., Ltd
Word of the day
Proto Oncogene Proteins c erbB 2
- cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.